2012年度中国药品审评报告

201220130228201220128315050FDA·6080GRP2012201220122012120125CRO20123737201141.1%201233.9%20122012=viewInfoCommon&id=312869CTDCTDCTDCTDCTD=largePage&id=31289820122012201238=changePage&pageName=serviceLcsy&frameStr=1252012152012214111891590201217019616182.1%3517.9%=init2012367381034080082361668295332012CIRS20125CIRSGoodReviewPracticeGRP911CIRSWHOISO-9001201289ISO-900110132012360DIAFDA20122012HIVHIV1.H20120561NNRTIHIV-1HIVFDA2011520122.H20120568HIV-1HIVHIV1.H20123294H20120066H20120067MDS20122.H20100776-78320120.3/101.H201301092.Z20120034,1.H201200202.H20130067H20130068H20130076-79ALKFDA20118201222012123.H20130069-72:H20120429-0433D25-5-HT2AH20123339H20123394β-newdelhimetalloβ-lactamase1,NDM-1NDM–120101191.H201204862011ACS+201172.H20120026(AT1)H201300091.H20120232β2-COPDCOPD2.H20120114H20120110H20120112H201201081220121.H201200762.H20120562-655-HT4,IXS20120053-56IXHIV201220126919112009201216500-7000201280%85%20124941332316182012200020121:20122:2012201213:31.170320112201220125944IND1234NDAANDA56IND2IND32012INDIND2012IND64.7%2011342012ANDA42012ANDA20952012722012ANDA60.7%10ANDA20.6%20121164201254612844:2012401632%30%5201120125INDNDA201220112012ANDA201155:5201242012520123ANDA1424NDA5.12012IND872%6-745%511%915%2012IND201257456:*47IND5.22012FDA20121.620125192.2012726727:20123.20121.7201245622012533458:20123.Copyright©AllRightReserved.11000388610-685855668610-68584189ICP09013725